The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
Health
Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes
Data assessed from 17 clinical trials of anti-amyloid drugs found no ‘meaningful effect’ on cognitive declineDrugs that ...
CitrixNews Staff
·
1 hour ago
Health
People in north of England twice as likely to be killed in accidents as Londoners, report finds
A man wearing a ‘falls detector’. RoSPA said falls from standing among elderly people were some of the most common acci...
CitrixNews Staff
·
2 hours ago
Health
Spotty insurance coverage for GLP-1 drugs gets worse
Health Care Spotty insurance coverage for GLP-1 drugs gets worse April 15, 20265:39 PM ET By Sydney Lupkin ...
CitrixNews Staff
·
4 hours ago
Health
Middle East conflict causes a fluoride shortage for US drinking water
Health Middle East conflict causes a fluoride shortage for US drinking water April 15, 20264:38 PM ET Pien Huang...
CitrixNews Staff
·
5 hours ago